Description of Gantenerumab Biosimilar - Anti-APP , Abeta42, Abeta40 mAb - Research Grade
General information on Anti-APP /Abeta42/Abeta40(Homo sapiens) (Gantenerumab) Monoclonal Antibody
Gantenerumab is under investigation for the treatment of Alzheimers Disease and targets IGF1 protein.
SDS-PAGE for Gantenerumab Biosimilar - Anti-APP , Abeta42, Abeta40 mAb
Gantenerumab Biosimilar - Anti-APP , Abeta42, Abeta40 mAb, on SDS-PAGE under reducing and non-reducing condition. The gel was stained overnight with Coomassie Blue. The purity of the antibody is greater than 95%.
Reviews
There are no reviews yet.